Cancer-fighting tea set for clinical trials in Ontario
'Dandelion root extract has very potent anti-cancer activity,' biochemist says
A Calgary company is involved in a clinical trial attempting to harness the potential cancer-fighting properties of a common weed.
AOR Inc. is developing a specially formulated dandelion root tea that will be tested on patients in Ontario.
"Dandelion has been used medicinally for centuries," George Templeton, director of operations at AOR, told CBC News. "In the last couple decades it's been started to be used for cancer treatments, mostly just through patients self-medicating."
The two groups were connected by a non-profit organization, Mitacs, which helped fund the project.
"We scientifically validated that dandelion root extract has very potent anti-cancer activity," said Dr. Siryaram Pandey, professor of biochemistry at the University of Windsor, According to Pandey, the tea is being developed as a therapeutic agent, not a nutritional supplement.
How the tea is made
After a year and a half of painstaking work, scientists at the Calgary lab have formulated a dandelion tea powder that is six to 10 times more potent than something available at a health food store. Dandelion root is milled, an extract is created and then freeze-dried.
The end product is a fine mustard coloured powder that patients can dissolve in hot water and drink. "We've gone through many trials to find what does work and what doesn't work," said Rachel Jacyszyn, research associate at AOR
"We finally found something that does work"
AOR is now working to produce 6,000 doses of the tea for a clinical trial at the Windsor Regional Cancer Centre.
Dr. Caroline Hamm, a medical oncologist at the Windsor Cancer Centre in Windsor, Ont. who is leading the study,she's seen improvements in some patients who drink dandelion root tea purchased at health food stores,
"Most of the responses that I have seen are very short. but there's a signal there that I think is worthwhile of further investigation," she said.
Hamm expects the trials to start within the next month.